KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Short-Term Debt repayments (2019 - 2025)

Boston Scientific (BSX) has disclosed Short-Term Debt repayments for 5 consecutive years, with $12.0 million as the latest value for Q3 2025.

  • Quarterly Short-Term Debt repayments changed N/A to $12.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 216.47% year-over-year, with the annual reading at $1.6 billion for FY2025, 216.47% up from the prior year.
  • Short-Term Debt repayments hit $12.0 million in Q3 2025 for Boston Scientific, down from $500.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $1.1 billion in Q1 2025 to a low of $12.0 million in Q3 2025.
  • Historically, Short-Term Debt repayments has averaged $469.8 million across 3 years, with a median of $500.0 million in 2025.
  • Biggest YoY gain for Short-Term Debt repayments was 114.88% in 2025; the steepest drop was 114.88% in 2025.
  • Year by year, Short-Term Debt repayments stood at $250.0 million in 2022, then skyrocketed by 101.6% to $504.0 million in 2024, then tumbled by 97.62% to $12.0 million in 2025.
  • Business Quant data shows Short-Term Debt repayments for BSX at $12.0 million in Q3 2025, $500.0 million in Q2 2025, and $1.1 billion in Q1 2025.